Literature DB >> 23728942

Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.

Sarah Elizabeth Wheeler1, Huifang Shi, Fangchen Lin, Sumana Dasari, Joseph Bednash, Stephen Thorne, Simon Watkins, Radhika Joshi, Sufi Mary Thomas.   

Abstract

BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) has had little improvement in mortality rates in decades. A clearer understanding of the HNSCC tumor microenvironment will aid in finding more effective targeted therapies for this disease. Tumor-associated fibroblasts (TAFs) are the largest stromal cellular components of the tumor microenvironment in HNSCC.
METHODS: We isolated TAFs from clinical HNSCC cases and propagated in vitro. The effects of TAF-secreted paracrine factors on in vitro HNSCC migration, invasion, and proliferation was assessed. The effect of TAFs on HNSCC growth and metastases was determined in an orthotopic floor-of-the-mouth tumor model.
RESULTS: TAF-conditioned media increased HNSCC cell migration, invasion, and proliferation. TAFs increased HNSCC tumor growth and metastases in vivo.
CONCLUSION: TAFs play a major role in increasing tumor growth and metastasis in HNSCC. Targeting the tumor stroma may be important to reduce the rate of HNSCC metastasis.
Copyright © 2013 Wiley Periodicals, Inc., A Wiley Company.

Entities:  

Keywords:  head and neck cancer; invasion; metastasis; tumor microenvironment; tumor-associated fibroblasts

Mesh:

Substances:

Year:  2013        PMID: 23728942      PMCID: PMC4111913          DOI: 10.1002/hed.23312

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  44 in total

1.  Peripheral blood fibrocytes: differentiation pathway and migration to wound sites.

Authors:  R Abe; S C Donnelly; T Peng; R Bucala; C N Metz
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

Review 2.  The stroma reaction myofibroblast: a key player in the control of tumor cell behavior.

Authors:  Alexis Desmoulière; Christelle Guyot; Giulio Gabbiani
Journal:  Int J Dev Biol       Date:  2004       Impact factor: 2.203

3.  Reconstruction of functionally normal and malignant human breast tissues in mice.

Authors:  Charlotte Kuperwasser; Tony Chavarria; Min Wu; Greg Magrane; Joe W Gray; Loucinda Carey; Andrea Richardson; Robert A Weinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-29       Impact factor: 11.205

4.  Smooth muscle actin-expressing stromal fibroblasts in head and neck squamous cell carcinoma: increased expression of galectin-1 and induction of poor prognosis factors.

Authors:  Jaroslav Valach; Zdeněk Fík; Hynek Strnad; Martin Chovanec; Jan Plzák; Zdeněk Cada; Pavol Szabo; Jana Sáchová; Miluše Hroudová; Markéta Urbanová; Martin Steffl; Jan Pačes; Jiří Mazánek; Cestmír Vlček; Jan Betka; Herbert Kaltner; Sabine André; Hans-Joachim Gabius; Roman Kodet; Karel Smetana; Peter Gál; Michal Kolář
Journal:  Int J Cancer       Date:  2012-04-09       Impact factor: 7.396

Review 5.  Incidence and sites of distant metastases from head and neck cancer.

Authors:  A Ferlito; A R Shaha; C E Silver; A Rinaldo; V Mondin
Journal:  ORL J Otorhinolaryngol Relat Spec       Date:  2001 Jul-Aug       Impact factor: 1.538

6.  Histopathological predictors of occult lymph node metastases in supraglottic squamous cell carcinomas.

Authors:  A Ozdek; S Sarac; M U Akyol; O F Unal; A Sungur
Journal:  Eur Arch Otorhinolaryngol       Date:  2000       Impact factor: 2.503

7.  Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element.

Authors:  J G Jiang; C Johnson; R Zarnegar
Journal:  J Biol Chem       Date:  2001-04-05       Impact factor: 5.157

Review 8.  Tumor-associated fibroblasts (part I): Active stromal participants in tumor development and progression?

Authors:  L A Kunz-Schughart; R Knuechel
Journal:  Histol Histopathol       Date:  2002-04       Impact factor: 2.303

9.  Elevated expression of TGF-beta1 in head and neck cancer-associated fibroblasts.

Authors:  Eben Rosenthal; Allison McCrory; Melissa Talbert; Geoff Young; Joanne Murphy-Ullrich; Candece Gladson
Journal:  Mol Carcinog       Date:  2004-06       Impact factor: 4.784

10.  The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells.

Authors:  L Rønnov-Jessen; O W Petersen; V E Koteliansky; M J Bissell
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  44 in total

1.  Cigarette Smoke Induces Metabolic Reprogramming of the Tumor Stroma in Head and Neck Squamous Cell Carcinoma.

Authors:  Marina Domingo-Vidal; Diana Whitaker-Menezes; Cristina Martos-Rus; Patrick Tassone; Christopher M Snyder; Madalina Tuluc; Nancy Philp; Joseph Curry; Ubaldo Martinez-Outschoorn
Journal:  Mol Cancer Res       Date:  2019-06-25       Impact factor: 5.852

2.  Inhibition of fibroblast growth factor receptor with AZD4547 mitigates juvenile nasopharyngeal angiofibroma.

Authors:  Tran Le; Jacob New; Joel W Jones; Shireen Usman; Sreeya Yalamanchali; Ossama Tawfik; Larry Hoover; Dan E Bruegger; Sufi Mary Thomas
Journal:  Int Forum Allergy Rhinol       Date:  2017-07-14       Impact factor: 3.858

3.  Development and Characterization of an In Vitro Model for Radiation-Induced Fibrosis.

Authors:  Dhruv Kumar; Sreeya Yalamanchali; Jacob New; Sean Parsel; Natalie New; Andrew Holcomb; Sumedha Gunewardena; Ossama Tawfik; Chris Lominska; Bruce F Kimler; Shrikant Anant; Kiran Kakarala; Terance Tsue; Yelizaveta Shnayder; Kevin Sykes; Subhash Padhye; Sufi Mary Thomas
Journal:  Radiat Res       Date:  2018-01-19       Impact factor: 2.841

4.  IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.

Authors:  L P Stabile; A M Egloff; M K Gibson; W E Gooding; J Ohr; P Zhou; N J Rothenberger; L Wang; J L Geiger; J T Flaherty; J R Grandis; J E Bauman
Journal:  Oral Oncol       Date:  2017-04-09       Impact factor: 5.337

Review 5.  Tumor Microenvironment in Head and Neck Squamous Cell Carcinomas.

Authors:  Görkem Eskiizmir
Journal:  Turk Arch Otorhinolaryngol       Date:  2015-09-01

Review 6.  Metastatic disease in head & neck oncology.

Authors:  Paolo Pisani; Mario Airoldi; Anastasia Allais; Paolo Aluffi Valletti; Mariapina Battista; Marco Benazzo; Roberto Briatore; Salvatore Cacciola; Salvatore Cocuzza; Andrea Colombo; Bice Conti; Alberto Costanzo; Laura Della Vecchia; Nerina Denaro; Cesare Fantozzi; Danilo Galizia; Massimiliano Garzaro; Ida Genta; Gabriela Alejandra Iasi; Marco Krengli; Vincenzo Landolfo; Giovanni Vittorio Lanza; Mauro Magnano; Maurizio Mancuso; Roberto Maroldi; Laura Masini; Marco Carlo Merlano; Marco Piemonte; Silvia Pisani; Adriele Prina-Mello; Luca Prioglio; Maria Gabriella Rugiu; Felice Scasso; Agostino Serra; Guido Valente; Micol Zannetti; Angelo Zigliani
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-04       Impact factor: 2.124

7.  Recent Advances in Head and Neck Tumor Microenvironment-Based Therapy.

Authors:  Muzafar A Macha; Nissar A Wani; Rais A Ganai; Ajaz A Bhat; Abid Hamid; Sheema Hashem; Mohammad Haris; Sham S Chauhan; Mohammad A Zargar; Surinder K Batra
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

8.  Cancer-Associated Fibroblasts Drive Glycolysis in a Targetable Signaling Loop Implicated in Head and Neck Squamous Cell Carcinoma Progression.

Authors:  Dhruv Kumar; Jacob New; Vikalp Vishwakarma; Radhika Joshi; Jonathan Enders; Fangchen Lin; Sumana Dasari; Wade R Gutierrez; George Leef; Sivapriya Ponnurangam; Hemantkumar Chavan; Lydia Ganaden; Mackenzie M Thornton; Hongying Dai; Ossama Tawfik; Jeffrey Straub; Yelizaveta Shnayder; Kiran Kakarala; Terance Ted Tsue; Douglas A Girod; Bennett Van Houten; Shrikant Anant; Partha Krishnamurthy; Sufi Mary Thomas
Journal:  Cancer Res       Date:  2018-05-16       Impact factor: 12.701

Review 9.  Targeting the Tumor Environment in Squamous Cell Carcinoma of the Head and Neck.

Authors:  Sandra Schmitz; Jean-Pascal Machiels
Journal:  Curr Treat Options Oncol       Date:  2016-07

Review 10.  TOX gene: a novel target for human cancer gene therapy.

Authors:  Xin Yu; Zheng Li
Journal:  Am J Cancer Res       Date:  2015-11-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.